- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06513000
Dryness Difference Between Before and After Phacoemulsification
July 18, 2024 updated by: Mohamed Samir, Sohag University
Evaluation Of Dry Eye After Uneventful Phacoemulsification
The aim of this study is to compare tear film and tear film secretion before and after phacoemulsificaton cataract surgery
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The tear film is a thin fluid layer overlies the ocular surface and provides the interface between the ocular surface and the external environment.
- It consists of three layers (lipid, aqueous and mucous) which act together to protect the corneal and conjunctival tissues and keeping them healthy.
- The superficial lipid layer is secreted by meibomian glands and functions as a smooth optical surface, reduces surface tension of the tear film, prevents anterior migration of aqueous tears on to the lid margin and retards evaporation .
- The Mucous layer is secreted by the goblet cells of the conjunctiva. It contains mucins that is very essential for lubrication, and wetting.
- The aqueous tear layer is mainly produced by the main lacrimal glands with small amounts produced by the goblet cells in the conjunctiva and accessory lacrimal glands and This layer acts by providing oxygen and nutrients to the avascular corneal tissue, washing away tissue debris, toxins, and foreign bodies, and also protecting the ocular surface from microbes.
- Cataract is the common cause of vision loss in the developing countries, also its rate of incidence increases with aging. So it is essential for those patients to undergo cataract surgeries to improve their vision and protect them from blindness.
- Phacoemulsification is the most recent cataract surgery at which a small incision is done then the ultrasonic power is used to fragment and emulsify the cataract. It was first introduced by Dr. Charlies Kelman and now Most surgeons prefer phacoemulsification surgery because of less postoperative astigmatism, faster stabilization of vision and refraction, and less postoperative inflammation
- Some surgical interventions related to the anterior segment may also cause dry eye and aggravate the symptoms of pre-existing dry eye, like PRK, LASIK, and cataract surgery by extra capsular cataract extraction, because a large incision is created in the eye during the procedure that sometimes damages the cornea and also can occur with phacoemulsification with a smaller incision.
- There are many tests that are used to estimate the degree of dryness and its severity which measure tear stability, tear production, and the presence of ocular surface disorders like Schirmer's test , which is used to evaluate tear production and the severity of dry eye by estimating the amount of special filter paper wetting that is put in the lower fornix for 5 minutes, and the Tears Break Up Time test, which is important to evaluate the tear film stability and evaporation.
- In this study we aim to evaluate dry eye affection after phacoemulsification whether it is worsen or not and the degree of increased dryness especially that dry eye syndrome is very common in our community and how phacoemulsification is now a frequent and preferred operation.
After taking a good detailed history The following assessments were performed in each patient before surgery and at the 2-week and 1-, 3-, and 6-month follow-up visits by the following tests:
- Non-invasive tear film break up time (TBUT), a parameter of tear film stability.
- Non-invasive tear meniscus height.
- Evaluation of Meibomian glands function.
- Lipid layer thickness.
- Eyelid margin.
- Analysis of conjunctival hyperemia.
Cornea sodium fluorescein staining.
- Schirmer I test, a measure of basic and reflex tear secretion, was performed without anesthesia. This test was performed by placing Schirmer strips over the lower lid margin; the strip wetting was measured and recorded in millimeters.
- Dry eye symptoms patients were classified as having dry eye disease if they reported experiencing one or more of the primary symptoms (soreness, scratchiness, dryness, grittiness, burning) often or constantly, the TBUT value was less than 10 seconds, and in Schirmer test I there is less than 10 mm wetting of filter paper for a period of 6 months or more after surgery.
- Visual acuity before and after surgery.
- Anterior segment examination by slit lamp.
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mohamed Samir zayed, Resident
- Phone Number: 002 01111485309
- Email: Doc.sad.2000@gmail.com
Study Locations
-
-
-
Sohag, Egypt
- Recruiting
- Sohag University Hospital
-
Contact:
- Mohamed Samir, Resident
- Phone Number: 002 01111485309
- Email: Doc.sad.2000@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
this study included 100 cataract patients, with age above 45 years old who underwent uncomplicated phacoemulsification surgery
Description
Inclusion criteria:
- Cataract patients.
- Cases within age > 45 years old.
Exclusion criteria:
- Patients with ocular surface diseases and eyelid abnormality.
- Patients receive ocular or systemic medications, that interfere with tear film production and stability (e.g. topical eye drops that contain preservatives, antihistaminic drugs, anticholinergic drugs, contraceptive pills).
- Patients with systemic diseases like diabetes, HTN, rheumatoid arthritis. - Patients underwent previous ocular surgeries that interfere with tears instability or production (e.g. refractive surgery, keratoplasty, eyelid surgeries, pterygium excision).
- Patients with a history of trauma, chemical burn, overusing contact lens (due to damaging the conjunctiva and the goblet cells, also corneal sensitivity reduction).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation Of Dryness Post Phacoemulcification In Non Complicated Cases using tear film break up time in seconds.
Time Frame: Before the operation and 2-week and 1, 3, and 6 month after the operation
|
Analysis of dryness before and after uncomplicated phacoemulsification using tear film break up time in seconds.
|
Before the operation and 2-week and 1, 3, and 6 month after the operation
|
|
Evaluation Of Dryness Post Phacoemulcification In Non Complicated Cases using tear meniscus height in millimeters.
Time Frame: Before the operation and 2-week and 1, 3, and 6 month after the operation
|
Analysis of dryness before and after uncomplicated phacoemulsification using tear meniscus height in millimeters.
|
Before the operation and 2-week and 1, 3, and 6 month after the operation
|
|
Evaluation Of Dryness Post Phacoemulcification In Non Complicated Cases using Lipid layer thickness in nanometers.
Time Frame: Before the operation and 2-week and 1, 3, and 6 month after the operation
|
Analysis of dryness before and after uncomplicated phacoemulsification using Lipid layer thickness in nanometers..
|
Before the operation and 2-week and 1, 3, and 6 month after the operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Hatem Gamal eldeen, Professor, Sohag University
- Study Chair: Mahmoud Mohamed farouk, Professor, Sohag University
- Study Chair: Hany Mahmoud, Lecturer, Sohag University
- Principal Investigator: Mohamed samir zayed, resident, Tahta ophthalmology hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Qin Y, Pan ZQ. [Recent advances in dry eye: etiology, pathogenesis and management]. Zhonghua Yan Ke Za Zhi. 2013 Sep;49(9):857-63. Chinese.
- Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci. 2008 Aug;85(8):668-74. doi: 10.1097/OPX.0b013e318181a947.
- Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Edrington T, Simpson T, Nelson JD, Begley C. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005 Jan;46(1):46-50. doi: 10.1167/iovs.03-0915.
- Pflugfelder SC, Stern ME. Biological functions of tear film. Exp Eye Res. 2020 Aug;197:108115. doi: 10.1016/j.exer.2020.108115. Epub 2020 Jun 16.
- Xue W, Zhu MM, Zhu BJ, Huang JN, Sun Q, Miao YY, Zou HD. Long-term impact of dry eye symptoms on vision-related quality of life after phacoemulsification surgery. Int Ophthalmol. 2019 Feb;39(2):419-429. doi: 10.1007/s10792-018-0828-z. Epub 2018 Feb 1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 12, 2024
Primary Completion (Estimated)
February 1, 2025
Study Completion (Estimated)
March 1, 2025
Study Registration Dates
First Submitted
July 8, 2024
First Submitted That Met QC Criteria
July 18, 2024
First Posted (Actual)
July 22, 2024
Study Record Updates
Last Update Posted (Actual)
July 22, 2024
Last Update Submitted That Met QC Criteria
July 18, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Dryness post phaco
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Universiti Sains MalaysiaNot yet recruitingDry Eye Disease (DED) | Dry Eye Symptoms | Dry Eye Syndrome (DES)Malaysia
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruitingDry Eye | Dry Eye Syndrome (DES)France
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
University of MiamiNot yet recruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
BioTissue Holdings, IncCompletedDry Eye | Dry Eye Disease (DED) | Dry Eye Disease With Severe KeratitisUnited States
-
The University of New South WalesUniversity of MelbourneRecruitingDry Eye Disease (DED)Australia
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Dry Eye Syndromes | Dry Eyes Chronic
-
Southern College of OptometryRecruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
Clinical Trials on Dry eye diagnostic system
-
Zhongnan HospitalRecruitingDry Eye | MGD-Meibomian Gland DysfunctionChina
-
Roweis adel youssefCairo UniversityRecruitingDry Eye Syndromes | Meibomian Gland Dysfunction | DrynessEgypt
-
Cairo UniversityCompletedDry Eye Disease | Retinal Nerve Fiber Layer | Chronic SmokingEgypt
-
Research Insight LLCCompleted
-
Sohag UniversityNot yet recruitingDry Eye Disease (DED) , Diabetic Macular EdemaEgypt
-
Assiut UniversityNot yet recruitingDry Eye Disease (DED) | Cataract (Post-operative Cataract Surgery Follow-up)
-
Alcon ResearchCompletedMeibomian Gland Dysfunction | Evaporative Dry Eye DiseaseUnited States
-
University Hospital "Sestre Milosrdnice"AbbVieActive, not recruitingDry Eye | Ocular Surface DiseaseCroatia
-
Chung Shan Medical UniversityCompleted